PARIS: French drugmaker Sanofi said it plans to enroll thousands of subjects globally for trials of an experimental vaccine for the coronavirus it is developing with GlaxoSmithKline, and that it has started to discuss advanced purchases with several countries. Sanofi is working on two vaccine …